These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 23601709

  • 1. Radiosynthesis and evaluation of [11C]EMPA as a potential PET tracer for orexin 2 receptors.
    Wang C, Moseley CK, Carlin SM, Wilson CM, Neelamegam R, Hooker JM.
    Bioorg Med Chem Lett; 2013 Jun 01; 23(11):3389-92. PubMed ID: 23601709
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and in vivo evaluation of [11C]MPTQ: a potential PET tracer for alpha2A-adrenergic receptors.
    Prabhakaran J, Majo VJ, Milak MS, Mali P, Savenkova L, Mann JJ, Parsey RV, Kumar JS.
    Bioorg Med Chem Lett; 2010 Jun 15; 20(12):3654-7. PubMed ID: 20529687
    [Abstract] [Full Text] [Related]

  • 3. Radiosynthesis of [11C]BBAC and [11C]BBPC as potential PET tracers for orexin2 receptors.
    Liu F, Majo VJ, Prabhakaran J, Castrillion J, Mann JJ, Martinez D, Kumar JS.
    Bioorg Med Chem Lett; 2012 Mar 15; 22(6):2172-4. PubMed ID: 22364813
    [Abstract] [Full Text] [Related]

  • 4. Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX(2) receptor.
    Malherbe P, Borroni E, Gobbi L, Knust H, Nettekoven M, Pinard E, Roche O, Rogers-Evans M, Wettstein JG, Moreau JL.
    Br J Pharmacol; 2009 Apr 15; 156(8):1326-41. PubMed ID: 19751316
    [Abstract] [Full Text] [Related]

  • 5. Crystal Structures of Human Orexin 2 Receptor Bound to the Subtype-Selective Antagonist EMPA.
    Suno R, Kimura KT, Nakane T, Yamashita K, Wang J, Fujiwara T, Yamanaka Y, Im D, Horita S, Tsujimoto H, Tawaramoto MS, Hirokawa T, Nango E, Tono K, Kameshima T, Hatsui T, Joti Y, Yabashi M, Shimamoto K, Yamamoto M, Rosenbaum DM, Iwata S, Shimamura T, Kobayashi T.
    Structure; 2018 Jan 02; 26(1):7-19.e5. PubMed ID: 29225076
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synthesis of [(11)C]MK-1064 as a new PET radioligand for imaging of orexin-2 receptor.
    Gao M, Wang M, Zheng QH.
    Bioorg Med Chem Lett; 2016 Aug 01; 26(15):3694-9. PubMed ID: 27268698
    [Abstract] [Full Text] [Related]

  • 9. Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5.
    Ametamey SM, Kessler LJ, Honer M, Wyss MT, Buck A, Hintermann S, Auberson YP, Gasparini F, Schubiger PA.
    J Nucl Med; 2006 Apr 01; 47(4):698-705. PubMed ID: 16595505
    [Abstract] [Full Text] [Related]

  • 10. Radiosynthesis and radiopharmacological evaluation of [N-methyl-11C]Org 34850 as a glucocorticoid receptor (GR)-binding radiotracer.
    Wuest F, Kniess T, Henry B, Peeters BW, Wiegerinck PH, Pietzsch J, Bergmann R.
    Appl Radiat Isot; 2009 Feb 01; 67(2):308-12. PubMed ID: 19071028
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Synthesis and in vivo evaluation of [11C]SA6298 as a PET sigma1 receptor ligand.
    Kawamura K, Ishiwata K, Tajima H, Ishii S, Shimada Y, Matsuno K, Homma Y, Senda M.
    Nucl Med Biol; 1999 Nov 01; 26(8):915-22. PubMed ID: 10708305
    [Abstract] [Full Text] [Related]

  • 13. 11C-labeling of n-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide derivatives and evaluation as potential radioligands for PET imaging of dopamine D3 receptors.
    Turolla EA, Matarrese M, Belloli S, Moresco RM, Simonelli P, Todde S, Fazio F, Magni F, Kienle MG, Leopoldo M, Berardi F, Colabufo NA, Lacivita E, Perrone R.
    J Med Chem; 2005 Nov 03; 48(22):7018-23. PubMed ID: 16250661
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of potential PET imaging probes for the orexin 2 receptors.
    Wang C, Wilson CM, Moseley CK, Carlin SM, Hsu S, Arabasz G, Schroeder FA, Sander CY, Hooker JM.
    Nucl Med Biol; 2013 Nov 03; 40(8):1000-5. PubMed ID: 23953751
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Synthesis and in vivo evaluation of [11C]SN003 as a PET ligand for CRF1 receptors.
    Kumar JS, Majo VJ, Sullivan GM, Prabhakaran J, Simpson NR, Van Heertum RL, Mann JJ, Parsey RV.
    Bioorg Med Chem; 2006 Jun 15; 14(12):4029-34. PubMed ID: 16529935
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and in vivo evaluation of [O-methyl-11C](2R,4R)-4-hydroxy-2-[2-[2-[2-(3-methoxy)phenyl]ethyl]phenoxy]ethyl-1-methylpyrrolidine as a 5-HT2A receptor PET ligand.
    Kumar JS, Prabhakaran J, Erlandsson K, Majo VJ, Simpson NR, Pratap M, Van Heertum RL, Mann JJ, Parsey RV.
    Nucl Med Biol; 2006 May 15; 33(4):565-74. PubMed ID: 16720250
    [Abstract] [Full Text] [Related]

  • 20. A PET imaging agent with fast kinetics: synthesis and in vivo evaluation of the serotonin transporter ligand [11C]2-[2-dimethylaminomethylphenylthio)]-5-fluorophenylamine ([11C]AFA).
    Huang Y, Narendran R, Bae SA, Erritzoe D, Guo N, Zhu Z, Hwang DR, Laruelle M.
    Nucl Med Biol; 2004 Aug 15; 31(6):727-38. PubMed ID: 15246363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.